黑料不打烊

Global Bladder Scanners Market Trends and Insights

Aging Population & Increasing Prevalence of Urological Conditions

By 2030, one in six people globally will be aged 60 or older, increasing the number of individuals susceptible to conditions such as benign prostatic hyperplasia and neurogenic bladder, both of which require regular post-void residual checks.^{[1]World Health Organization, 鈥淎geing and Health,鈥� who.int} In Japan, the demographic challenge is evident: the percentage of individuals aged 65 and older is set to rise from 29.3% in 2024 to an estimated 34.8% by 2040, straining hospital capacities and promoting home-based bladder monitoring.^{[2]Statistics Bureau of Japan, 鈥淧opulation Estimates Monthly Report,鈥� stat.go.jp} Research indicates that postoperative urinary retention impacts up to 70% of specific surgical groups, while the risk of daily catheter-associated urinary tract infections (CAUTIs) from extended catheter use stands at 3-7%. As a result, non-invasive scanners play a pivotal role in infection prevention and align with value-based contracts that impose financial penalties for readmissions due to device-related urinary tract infections.

Surge in Point-of-Care Ultrasound Adoption in ED & Peri-Operative Care

Emergency departments have integrated ultrasound triage, reducing the time for diagnosing urinary retention from 45 minutes (previously reliant on radiology referrals) to under 5 minutes at the bedside. The Enhanced Recovery After Surgery pathways stipulate catheter removal on the first postoperative day, necessitating prompt assessments of residuals to prevent bladder overdistension. In 2024, the American College of Emergency Physicians officially designated bladder ultrasound as a core competency; as a result, residency programs now require 25 supervised scans for board eligibility.^{[3]Agency for Healthcare Research and Quality, 鈥淭oolkit for Reducing Catheter-Associated Urinary Tract Infections,鈥� ahrq.gov} Consequently, hospitals are gravitating towards portable ultrasound units, priced between USD 8,000-15,000, which achieve break-even points more swiftly than traditional carts exceeding USD 30,000.

AI-Enabled 3-D Volumetric Imaging Enhancing Diagnostic Accuracy & Billing Compliance

While traditional 2-D ellipsoid calculations can err by 卤20% with irregular bladder geometries, AI-driven 3-D reconstructions reduce this error to under 10% and minimize operator variability. In 2025, FUJIFILM Sonosite unveiled a 46 megahertz probe that offers sub-millimeter resolution, enhancing scans for pediatric and obese patients. Automated reporting systems now seamlessly integrate with electronic medical records, auto-filling Current Procedural Terminology 51798 fields. This innovation has led to a 15-20% increase in billable scan volumes during the first year at select U.S. pilot sites.

ERAS Protocols Opt for Scanning Over Routine Catheterization

As per the 2024 updates to colorectal and orthopedic Enhanced Recovery After Surgery guidelines, indwelling catheter use is now capped at under 24 hours. Nursing staff is directed to depend on bladder scanning post this period. A 2025 meta-analysis highlighted a reduction in catheter reinsertion rates among hip-arthroplasty patients, dropping from 18% to 7% with the implementation of nurse-led scanning protocols.^{[4]Diagnostics, 鈥淭hree-Dimensional Ultrasound Bladder Volume Measurement Accuracy,鈥� mdpi.com} In 2023, U.S. Ambulatory Surgery Centers, which conducted 38,600 knee arthroplasties, began using handheld scanners to meet same-day discharge requirements.^{[5]Centers for Disease Control and Prevention, 鈥淐atheter-associated Urinary Tract Infections,鈥� cdc.gov}

High capital cost and limited budgets in small practices

Entry-level portable scanners are priced at USD 8,000, while comprehensive three-dimensional (3-D) artificial intelligence (AI) platforms soar to USD 35,000, significantly exceeding the annual equipment budgets of rural clinics. The United States Medicare reimburses approximately USD 25 for each Current Procedural Terminology (CPT) 51798 scan. This reimbursement structure necessitates that low-volume offices perform between 320 to 1,400 procedures just to break even on their initial investment. While leasing options and the refurbished market provide some financial relief, a 7.5% tariff on finished scanners in India results in end-user prices being 15-20% steeper than those in North America.

Shortage of Trained Sonographers in Rural LMICs

By 2030, the World Health Organization predicts a shortfall of 11 million health workers, particularly imaging specialists, who are predominantly found in urban hospitals. AI-driven handheld devices, such as the Butterfly iQ+ Bladder, can annotate directly on smartphone screens, simplifying their usage. However, they still require certified oversight in regulated environments. Adoption is also hindered by Nigeria's electricity challenges, with 68% of clinics lacking a consistent 8-hour power supply.

Segment Analysis

By Product Type: 3-D Scanners Gain Traction Despite 2-D Dominance

In 2025, two-dimensional devices commanded a dominant 52.18% share of the bladder scanner market, due to their integration into established nursing workflows and appealing price points. Meanwhile, three-dimensional scanners are projected to grow at a robust 7.50% compound annual growth rate (CAGR), driven by urologists' demand for volumetric precision in cases like prolapse and neurogenic bladder. In 2025, FUJIFILM unveiled a 46 MHz transducer, enhancing pediatric applications, and Canon rolled out dual-mode platforms, allowing seamless toggling between 2-D and 3-D imaging without probe changes. As we look ahead, price reductions from semiconductor-based arrays are expected to bridge the gap between basic 2-D and entry-level 3-D units, hastening the shift in technology adoption in Ambulatory Surgical Centers (ASCs) and educational hospitals. 

Additionally, artificial intelligence (AI)-driven reimbursement incentives bolster this momentum. Medicare's automated data extraction from 3-D systems simplifies auditing, encouraging financial managers to modernize their equipment. While the European Union's post-market surveillance under the Medical Device Regulation (MDR) leans towards the decade-long safety track record of 2-D systems, hospitals are increasingly recognizing the clinical advantages of 3-D precision in intricate urological procedures. Consequently, while 2-D systems will continue to lead in volume, all new growth is set to favor 3-D systems through 2031.

By Portability: Cart-Based Systems Anchor Hospital Workflows

In 2025, cart-based platforms dominated the bladder scanner market, accounting for 64.70% of the market share. Their success is attributed to seamless integration with electronic medical records and robust battery life, allowing emergency departments to scan up to 100 patients daily. These carts, equipped with 12-inch displays and mobile wheeled stands, facilitate easy movement across departments, a feature highly valued by infection-control committees. Looking ahead, this sub-segment is projected to grow at a 6.38% CAGR until 2031, driven by hospitals in Latin America and Southeast Asia modernizing their radiology fleets.

Handheld scanners priced below USD 8,000 are experiencing rapid adoption in home care settings, rural clinics, and even veterinary practices, especially following Butterfly Network's collaboration with Clipper in 2025. While these handheld devices forgo standalone displays by connecting to smartphones, they must adhere to Food and Drug Administration (FDA) mobile health guidelines, necessitating accuracy validation across diverse handset models. On the other hand, bench-top units, though still present in dialysis centers and long-term care wards due to their alignment with consistent patient flow, are experiencing stagnant sales.

By Technology: AI Imaging Disrupts Conventional Workflows

In 2025, conventional imaging commanded a dominant 66.88% market share, underscoring the significant presence of hospitals hesitant about artificial intelligence (AI) validation. Meanwhile, AI-driven imaging is projected to grow at a robust 6.89% CAGR. This surge is attributed to deep-learning models that can now deliver results in under 30 seconds and automatically populate Current Procedural Terminology (CPT) reporting fields. Notably, Butterfly鈥檚 Ultrasound-on-Chip integrates inference models directly on the probe, effectively sidestepping cloud latency and ensuring compliance with General Data Protection Regulation (GDPR) regulations in Europe.

Industry giants GE Healthcare and Siemens Healthineers are modernizing older imaging carts, either through software enhancements or by acquiring licenses for third-party algorithms. Furthermore, the Food and Drug Administration's (FDA) 2024 guidelines on machine learning emphasize the need for ongoing performance evaluations, a move that favors vendors with substantial clinical trial funding.

Note: Segment shares of all individual segments available upon report purchase

By End User: Ambulatory Surgical Centers Outpace Hospitals

Hospitals and clinics lead the charge, conducting up to 200 bladder scans daily across emergency, urology, and perioperative units. Meanwhile, Ambulatory Surgery Centers (ASCs), buoyed by a 15.4% Medicare payment surge in 2023, are not only registering the swiftest growth at a 6.47% CAGR but are also expanding the bladder scanner market. They're doing this by investing in portable scanners, ensuring same-day discharges. Knee arthroplasty volumes surged by 257% from 2020 to 2023, with each procedure necessitating residual checks before patient release.

Home-health agencies are gaining traction, due to Medicare's 2024 remote monitoring expansion, which now reimburses bladder volume tracking for heart-failure and spinal-injury patients. While diagnostic imaging chains and rehabilitation centers maintain a steady demand, long-term care facilities are turning to affordable handhelds to reduce Catheter-Associated Urinary Tract Infection (CAUTI) incidences among their elderly residents.

By Application: Urology and Emergency Medicine Lead Adoption

In 2025, urology accounted for 44.40% of the revenue, while obstetrics and gynecology are projected to grow at the fastest rate, with a CAGR of 7.44% through 2031. Urology continues to dominate, utilizing 3-D precision for residual measurements in cases like benign prostatic hyperplasia and spinal cord injuries. Emergency medicine sees the most significant growth, as bedside bladder scanning not only reduces evaluation time for acute retention but also ensures timely adherence to quality metrics. Obstetrics focuses on postpartum retention issues, whereas gynecology uses scanners to minimize catheter use after pelvic surgery.

Perioperative surgery integrates scanners into Enhanced Recovery After Surgery (ERAS) protocols, leading to lower reinsertion rates and shorter hospital stays, bolstering the bladder scanner market. Rehabilitation centers synchronize scanner applications with intermittent catheterization, highlighting a consistent, albeit specialized, demand.

Note: Segment shares of all individual segments available upon report purchase

Geography Analysis

North America generated 38.74% of global revenue in 2025, anchored by CMS payment models that reward CAUTI reduction and by widespread AI-enabled ultrasound familiarity among clinicians. Ongoing FDA quality-system updates slated for 2026 are expected to harmonize manufacturing benchmarks, reducing procurement risk for providers.

Asia-Pacific is forecast to post a 6.85% CAGR through 2031, underpinned by expanding healthcare investments and accelerating POCUS training programs. China and India spearhead volume demand as tertiary centers adopt 3D scanners for surgical wards, while Japan and South Korea emphasize AI algorithms that align with national digital-health strategies. Australia and Southeast-Asian markets favor portable units compatible with constrained clinical footprints.

Europe shows balanced growth amid CE-mark standardization and infection-prevention campaigns integrating bladder scanners into national quality frameworks. Germany, France, Italy, Spain, and the United Kingdom drive adoption based on public-insurance reimbursement, whereas Central and Eastern European countries adopt through donor-funded procurement. South America and Middle East & Africa remain nascent yet promising as infrastructure upgrades prioritize affordable, easy-to-train modalities in high-burden urological settings.